Osmopharm S.A. is a Swiss pharmaceutical contract manufacturer that specializes in the development and production of modified release solid oral dosage forms. The company focuses on creating innovative oral drug delivery systems to achieve optimal therapeutic activity. Osmopharm S.A. is cGMP certified by the Swiss health authority Swissmedic, with a certificate that holds European validity due to the mutual recognition agreement between the EU and Switzerland. Adhering to quality standards defined by PIC/S (Pharmaceutical Inspection Convention/Co-Operation Scheme), the company boasts a production capacity of 36 tons per month of non-sterile products. With over 150 formulations developed since its inception, Osmopharm S.A. is a key player in the pharmaceutical manufacturing sector.

Services include:

- Anatomical Therapeutic Chemical (ATC) Classification
- Regulatory Services
- Solid Dosage
- Packaging

Osmopharm S.A. is committed to maintaining high standards in pharmaceutical manufacturing while providing a comprehensive range of services tailored to meet the needs of its clients in the industry. For more information, please visit osmopharm.com.